(Date:5/16/2008)... Nationwide Fundraiser Seeks to Raise $38 Milli...ay 16 /PRNewswire-USNewswire/ -- Walkers in nearly...this weekend -- May 17 and,18 -- by participating ...ser, the Cystic Fibrosis Foundation announced toda...th. Cystic fibrosis is a,life-threatening genetic ...
(Date:5/16/2008)... ,What this country needs is more unemployed polit...PRNewswire-FirstCall/ -- Although nearly all,voter...rtant issues" list,a looming federal budgetary cr...by any of the current presidential candidates is l... Senate Majority Leader Bill Frist., Jousting wit...
(Date:5/16/2008)... WASHINGTON, May 16 /PRNewswire-USNewswire/ -- ... area of the Irrawaddy delta, survivors of,Cyclone...e problems. Many,survivors still need assistance, ...re creating an increasingly dire situation., "The...ore help to,recover from this disaster and get bac...
(Date:5/16/2008)... NEWPORT BEACH, Calif., May 16 /PRNewswire-Firs...: NHP ) announced today the promotion of David,M....tment Officer. "Dave,has made a tremendous contrib...ced by our strong investment growth and diversific...e for over $1 billion in accretive,investments for...
Breaking Medicine News(10 mins):Health News:GREAT STRIDES Walks for Cystic Fibrosis Slated for 47 States This Weekend 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 3Health News:Myanmar Cyclone Survivors Face New Challenges 2Health News:David M. Boitano Promoted to Senior Vice President 2(Date:5/15/2008)..., Switzerland, May 15 /- Patients wit...most common cancers, can expect,further treatment ...in(R),(trastuzumab) following new data that is bei...cal Oncology (ASCO) annual meeting in Chicago at,t...attend the meeting which,is the premier event for ...
(Date:5/15/2008)...I Data Presented at ASCO Showed Acceptable Tolerab...rade 3 and 4 Neuropathy, WOODCLIFF LAKE, N.J., Ma...apeutic agent eribulin mesylate (E7389) demonstrat...women with locally advanced or metastatic,breast c...e II clinical,trial. The study also suggests that ...
(Date:5/15/2008)...ssure reductions demonstrated in Blacks, Hispanics...d Obese Individuals, PARSIPPANY, N.J., May 15 /PR... that data presented at the American Society of,Hy...ng (ASH 2008) in New,Orleans demonstrated that the...d olmesartan medoxomil) safely and effectively hel...
(Date:5/15/2008)...ZELL, Switzerland, May 15 /- Ergonex ... and Drug Administration (FDA) has,granted orphan ... pulmonary,arterial hypertension (PAH). Terguride ...Phase II trial in Europe., "The FDA,s grant of or...ges and strengthens our development program by off...
Breaking Medicine Technology:New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 2New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 3New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 4New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 5New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 6Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 2Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2007 Financial Results 1582 1deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2007 Financial Results 1582 2Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals 697 1Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals 697 2Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals 697 3AIDS Stopped in Haiti Before U S 4956 1AIDS Stopped in Haiti Before U S 4956 2AIDS Stopped in Haiti Before U S 4956 3ShangPharma Receives Strategic Investment from TPG 1577 1ShangPharma Receives Strategic Investment from TPG 1577 2ShangPharma Receives Strategic Investment from TPG 1577 3ShangPharma Receives Strategic Investment from TPG 1577 4..., July 9 /CNW/ - Insmed Inc. (NASDAQ:INSM), a ,bio...and approval,of drugs for the treatment of metabo...nced that it will present at this,week,s C.E. Unt...s Conference in New York City. , The conference...,York City, will run from Tuesday, July 10th thro...
...(BUSINESS WIRE)--Jul 9, 2007 - Neose Technologies,... present at the,C.E. Unterberg, Towbin Emerging Gr... Oriental Hotel in New York City from July,10-12, ...2:00 p.m.,(EDT) on Tuesday, July 10, 2007. The pre...eplay via the following link:, http://www.wsw.com/...
Other Medicine Technology:Insmed Inc. to Present at C.E. Unterberg, Towbin Growth Conference 2...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
Medicine Products: